
Niosome-based delivery systems for olanzapine: Formulation, characterisation, and kinetic evaluation
Scutellarin mitigates LPS-ATP-induced cardiomyocyte pyroptosis through the inhibition of the NLRP3/caspase-1/GSDMD signalling pathway
Recent advances in the treatment of non-alcoholic fatty liver disease with astragaloside IV
Impact of peroxide content in excipients and antioxidants on famotidine oxidative stability
Please submit your manuscripts exclusively to the editorial office of Acta Pharmaceutica via email:
acta.pharmaceutica@farmaceut.org or svjetlana.luterotti@gmail.com or svjetlana.luterotti@pharma.hr
Only submissions received from authentic institutional e-mail addresses will be further processed.
PUBLICATION CHARGES
Because of the high cost of preparing and publishing articles in Acta Pharmaceutica payment of publication fee is mandatory for all articles accepted for publication. Current charge is 1500 € per manuscript (excl. VAT). For more information please visit Information for Authors and Reviewers.
Open Access Statement
This is an open access journal that provides free, immediate, and unrestricted online access to all its published content for readers around the world.